Blog - Page 2 of 1881 - World Asthma Foundation

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Condition: AsthmaInterventions: Drug: Fluticasone furoate (FF) Dry Powder Inhaler; Drug: Fluticasone propionate (FP) Dry Powder Inhaler; Drug: Budesonide (BUD) Turbuhaler; Drug: Placebo (ELLIPTA or DISKUS)Sponsor: GlaxoSmithKlineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | December 17, 2016 | Asthma Clinical Trials U.S. | No Comments |

Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study

Condition: AsthmaIntervention: Device: anharmonic morphological analysis of the respiratory signals (AMARS)Sponsor: University Hospital, BordeauxRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | December 14, 2016 | Asthma Clinical Trials U.S. | No Comments |

Chronic Widespread Pain and White Blood Cell Activation

Condition: Widespread Chronic PainInterventions: Drug: Ketotifen Fumarate; Drug: Placebo; Other: Standard of CareSponsors: McGill University Health Center; The Louise And Alan Edwards FoundationRecruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | December 11, 2016 | Asthma Clinical Trials U.S. | No Comments |

Identifying Patients With the COPD-Asthma Overlap Phenotype: Therapeutic Implications

Condition: COPD AsthmaIntervention: Sponsor: Clalit Health ServicesRecruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | December 8, 2016 | Asthma Clinical Trials U.S. | No Comments |

Optimization of substituted imidazobenzodiazepines as novel asthma treatments.

Optimization of substituted imidazobenzodiazepines as novel asthma treatments. Eur J Med Chem. 2016 Nov 24;126:550-560 Authors: Jahan R, Stephen MR, Forkuo GS, Kodali R, Guthrie ML, Nieman AN, Yuan NY, Zahn NM, Poe MM, Li G, Yu OB, Yocum GT,…

By admin | December 6, 2016 | U.S. National Library of Medicine (NIH) | No Comments |

Association of interleukin-18 and asthma.

Association of interleukin-18 and asthma. Inflammation. 2016 Dec 02; Authors: Xu MH, Yuan FL, Wang SJ, Xu HY, Li CW, Tong X Abstract Cytokine-mediated immunity plays a dominant role in the pathogenesis of various immune diseases, including asthma. The recent…

By admin | December 5, 2016 | U.S. National Library of Medicine (NIH) | No Comments |

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

Condition: AsthmaInterventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: PlaceboSponsor: Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | December 5, 2016 | Asthma Clinical Trials U.S. | No Comments |

Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study

Condition: Severe AsthmaIntervention: Sponsors: Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA); University Medical Center GroningenRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | December 2, 2016 | Asthma Clinical Trials U.S. | No Comments |

Association of Allergic Rhinitis and Sinusitis with Childhood Asthma.

Association of Allergic Rhinitis and Sinusitis with Childhood Asthma. Indian Pediatr. 2016 Nov 5;: Authors: Kumar S, Singh M, Das RR, Mathew JL, Saxena AK Abstract BACKGROUND: To study the point prevalence of allergic rhinitis and sinusitis in childhood asthma…

By admin | November 29, 2016 | U.S. National Library of Medicine (NIH) | No Comments |

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy

Condition: Idiopathic AngioedemaInterventions: Drug: Omalizumab; Drug: PlacebosSponsors: University of Wisconsin, Madison; Novartis PharmaceuticalsNot yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

By admin | November 29, 2016 | Asthma Clinical Trials U.S. | No Comments |